نتایج جستجو برای: foxa1

تعداد نتایج: 520  

Journal: :The EMBO journal 2011
Jessica L L Robinson Stewart Macarthur Caryn S Ross-Innes Wayne D Tilley David E Neal Ian G Mills Jason S Carroll

Breast cancer is a heterogeneous disease and several distinct subtypes exist based on differential gene expression patterns. Molecular apocrine tumours were recently identified as an additional subgroup, characterised as oestrogen receptor negative and androgen receptor positive (ER- AR+), but with an expression profile resembling ER+ luminal breast cancer. One possible explanation for the appa...

2015
Ellen Johansson Louise Andersson Jessica Örnros Therese Carlsson Camilla Ingeson-Carlsson Shawn Liang Jakob Dahlberg Svante Jansson Luca Parrillo Pietro Zoppoli Guillermo O. Barila Daniel L. Altschuler Daniela Padula Heiko Lickert Henrik Fagman Mikael Nilsson

Current understanding infers a neural crest origin of thyroid C cells, the major source of calcitonin in mammals and ancestors to neuroendocrine thyroid tumors. The concept is primarily based on investigations in quail–chick chimeras involving fate mapping of neural crest cells to the ultimobranchial glands that regulate Ca homeostasis in birds, reptiles, amphibians and fishes, but whether mamm...

Journal: :The EMBO journal 2011
Si Kee Tan Zhen Hua Lin Cheng Wei Chang Vipin Varang Kern Rei Chng You Fu Pan Eu Leong Yong Wing Kin Sung Edwin Cheung

Oestrogen receptor α (ERα) is key player in the progression of breast cancer. Recently, the cistrome and interactome of ERα were mapped in breast cancer cells, revealing the importance of spatial organization in oestrogen-mediated transcription. However, the underlying mechanism of this process is unclear. Here, we show that ERα binding sites (ERBS) identified from the Chromatin Interaction Ana...

Journal: :Molecular cancer research : MCR 2015
Kouhei Sakurai Brian J Reon Jordan Anaya Anindya Dutta

UNLABELLED Long noncoding RNAs (lncRNA) are emerging as major regulators of cellular phenotypes and implicated as oncogenes or tumor suppressors. Here, we report a novel tumor-suppressive locus on human chromosome 15q23 that contains two multiexonic lncRNA genes of 100 kb each: DRAIC (LOC145837) and the recently reported PCAT29. The DRAIC lncRNA was identified from RNA-seq data and is downregul...

2014
Na Shen Jing Gong Ying Wang Jing Tian Jiaming Qian Li Zou Wei Chen Beibei Zhu Xinghua Lu Rong Zhong Anyuan Guo Li Wang Xiaoping Miao

The human forkhead box A1 (FOXA1) and A2 (FOXA2) transcription factors have been found to control estrogen and androgen signaling through co-regulating target genes with sex hormone receptors. Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk. Firstly we...

2013
Qian Li Yu Zhang Jingxuan Fu Limin Han Lixiang Xue Cuicui Lv Pan Wang Guodong Li Tanjun Tong Anke Sparmann

As you can see below, all referees appreciate the demonstration that FoxA1 promotes cellular senescence via the transcriptional activation of p16INK4a. However, the principal concern expressed by at least two reviewers is that the study remains too preliminary at this stage. In particular, the molecular mechanism by which FoxA1 modulates PRC function remains vague and requires further substanti...

2013
Michael N. C. Fletcher Mauro A. A. Castro Xin Wang Ines de Santiago Martin O’Reilly Suet-Feung Chin Oscar M. Rueda Carlos Caldas Bruce A. J. Ponder Florian Markowetz Kerstin B. Meyer

The fibroblast growth factor receptor 2 (FGFR2) locus has been consistently identified as a breast cancer risk locus in independent genome-wide association studies. However, the molecular mechanisms underlying FGFR2-mediated risk are still unknown. Using model systems we show that FGFR2-regulated genes are preferentially linked to breast cancer risk loci in expression quantitative trait loci an...

Journal: :Molecular and cellular endocrinology 2013
S Belikov C Öberg T Jääskeläinen V Rahkama J J Palvimo Ö Wrange

Prostate cancer growth depends on androgens. Synthetic antiandrogens are used in the cancer treatment. However, antiandrogens, such as bicalutamide (BIC), have a mixed agonist/antagonist activity. Here we compare the antiandrogenic capacity of BIC to a new antiandrogen, MDV3100 (MDV) or Enzalutamide™. By reconstitution of a hormone-regulated enhancer in Xenopus oocytes we show that both antagon...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید